SLS vs. BHC, AUP, CARA, CRON, TEV, ABT, NOT, PYR, NVO, and DNA
Should you be buying Solaris Resources stock or one of its competitors? The main competitors of Solaris Resources include Bausch Health Companies (BHC), Aurinia Pharmaceuticals (AUP), Cara Operations (CARA), Cronos Group (CRON), Tervita (TEV), Absolute Software Co. (ABT.TO) (ABT), Noront Resources (NOT), PyroGenesis Canada Inc. (PYR.V) (PYR), Novo Resources Corp. (NVO.V) (NVO), and Dalradian Resources (DNA). These companies are all part of the "pharmaceutical products" industry.
Solaris Resources vs. Its Competitors
Bausch Health Companies (TSE:BHC) and Solaris Resources (TSE:SLS) are both pharmaceutical products companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.
Bausch Health Companies has a beta of 0.77, meaning that its share price is 23% less volatile than the S&P 500. Comparatively, Solaris Resources has a beta of 1.9, meaning that its share price is 90% more volatile than the S&P 500.
Solaris Resources has lower revenue, but higher earnings than Bausch Health Companies. Bausch Health Companies is trading at a lower price-to-earnings ratio than Solaris Resources, indicating that it is currently the more affordable of the two stocks.
Solaris Resources has a consensus target price of C$14.50, indicating a potential upside of 92.56%. Given Solaris Resources' stronger consensus rating and higher possible upside, analysts plainly believe Solaris Resources is more favorable than Bausch Health Companies.
In the previous week, Solaris Resources had 1 more articles in the media than Bausch Health Companies. MarketBeat recorded 1 mentions for Solaris Resources and 0 mentions for Bausch Health Companies. Solaris Resources' average media sentiment score of 0.00 beat Bausch Health Companies' score of -0.67 indicating that Solaris Resources is being referred to more favorably in the news media.
79.0% of Bausch Health Companies shares are owned by institutional investors. Comparatively, 25.1% of Solaris Resources shares are owned by institutional investors. 11.3% of Bausch Health Companies shares are owned by insiders. Comparatively, 40.6% of Solaris Resources shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Solaris Resources has a net margin of 0.00% compared to Bausch Health Companies' net margin of -1.88%. Bausch Health Companies' return on equity of 15.87% beat Solaris Resources' return on equity.
Summary
Solaris Resources beats Bausch Health Companies on 11 of the 15 factors compared between the two stocks.
Get Solaris Resources News Delivered to You Automatically
Sign up to receive the latest news and ratings for SLS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SLS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Solaris Resources Competitors List
Related Companies and Tools
This page (TSE:SLS) was last updated on 7/5/2025 by MarketBeat.com Staff
